{"id":5733,"date":"2025-11-25T09:57:42","date_gmt":"2025-11-25T09:57:42","guid":{"rendered":"https:\/\/pharmanomos.ch\/medical-devices-and-european-regulations-implications-for-swiss-companies\/"},"modified":"2026-04-28T06:07:23","modified_gmt":"2026-04-28T06:07:23","slug":"medical-devices-and-european-regulations-implications-for-swiss-companies","status":"publish","type":"post","link":"https:\/\/pharmanomos.ch\/en\/medical-devices-and-european-regulations-implications-for-swiss-companies\/","title":{"rendered":"Medical Devices and European Regulations: Implications for Swiss Companies"},"content":{"rendered":"\n

What the MDR Regulation entails for manufacturers, importers and distributors in Switzerland<\/strong><\/p>\n\n

\n

“Compliance is not an administrative goal, but the foundation of trust in the market.”<\/em><\/p>\n<\/blockquote>\n\n

With the entry into force of Regulation (EU) 2017\/745(MDR<\/strong>), the medical device industry has undergone one of the most profound regulatory changes in decades. For Swiss companies-manufacturers, importers, and distributors-implementation of the MDR poses a particular challenge, especially after the failure to sign the Institutional Framework Agreement between Switzerland and the EU, which led to the absence of the updated Mutual Recognition Agreement (MRA). <\/p>\n\n

In this new scenario, understanding the practical implications of MDR is essential to remain competitive, ensure compliance and preserve access to the European market.<\/p>\n\n

<\/div>\n\n

MDR: what changes for Switzerland<\/h2>\n\n

As of May 26, 2021, with the full entry into force of the MDR, Switzerland officially became a third country<\/strong> to the EU. This has led to important consequences: <\/p>\n\n

1. End of automatic recognition of compliance<\/strong><\/h3>\n\n

Mutual recognition of conformity assessments between CH and EU is no longer automatic.Swiss companies must therefore adapt to the requirements for economic operators from third countries.<\/p>\n\n

2. Mandatory introduction of the figure of the EU Importer<\/strong><\/h3>\n\n

To export devices to the European market, a Swiss manufacturer must appoint an importer established in the EU<\/strong> with responsibilities defined by the MDR.<\/p>\n\n

3. Need for a European Representative (EC-REP).<\/strong><\/h3>\n\n

For Swiss manufacturers, the designation of an EU authorized representative<\/strong> is mandatory to place devices on the European market.<\/p>\n\n

4. Updated labeling and traceability<\/strong><\/h3>\n\n

They must appear on packaging and documents:<\/p>\n\n